Cargando…

pVAX-WIF-1真核表达载体的构建及其抗肺癌作用

BACKGROUND AND OBJECTIVE: WIF-1 is an important tumor-suppressing gene in lung cancer, and its encoding protein WIF-1 can reduce proliferation and promote apoptosis by inhibiting Wnt/β-catenin signaling in lung cancer. This study constructs a eukaryotic expression plasmid carrying WIF-1 using FDA-ap...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000242/
https://www.ncbi.nlm.nih.gov/pubmed/26182865
http://dx.doi.org/10.3779/j.issn.1009-3419.2015.07.04
_version_ 1783331654352240640
collection PubMed
description BACKGROUND AND OBJECTIVE: WIF-1 is an important tumor-suppressing gene in lung cancer, and its encoding protein WIF-1 can reduce proliferation and promote apoptosis by inhibiting Wnt/β-catenin signaling in lung cancer. This study constructs a eukaryotic expression plasmid carrying WIF-1 using FDA-approved clinical plasmid pVAX and explores the anti-tumor effect of pVAX-WIF-1 on A549 lung cancer cells in vitro and vivo. METHODS: The DNA fragment of human WIF-1 coding sequence was amplified by PCR and was cloned into the multiple cloning sites of eukaryotic expression vector pVAX to construct pVAX-WIF-1. A recombinant plasmid was transfected into lung cancer A549 cells, and the expression of WIF-1 genes was verified by Western blot after transfection. Subsequently, the effect of pVAX-WIF-1 on cell apoptosis and proliferation was identified by MTT assay, staining A549 cells with Hoechst 3235, and flow cytometry. Finally, the A549 subcutaneous xenograft was established to detect the effect of pVAX-WIF-1 on lung tumor growth in vivo. RESULTS: The results of restriction enzyme digestion, PCR, and sequencing indicated that eukaryotic expression plasmid pVAX-WIF-1 was successfully constructed. The protein expression level of WIF-1 was increased in the transfected A549 cells. Further results showed that transfection with pVAX-WIF-1 significantly inhibited proliferation and promoted apoptosis in A549 cells. Moreover, pVAX-WIF-1 significantly inhibited the tumor growth of the A549 subcutaneous xenograft in vivo. CONCLUSION: The recombinant eukaryotic expression vector pVAX-WIF-1 was successfully constructed. Transfection with pVAX-WIF-1 could significantly inhibit proliferation and promote apoptosis of lung cancer A549 cells and also effectively inhibit the tumor growth of the A549 subcutaneous xenograft in vivo. Our research can contribute to clinical applications of WIF-1 in lung cancer gene therapy.
format Online
Article
Text
id pubmed-6000242
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60002422018-07-06 pVAX-WIF-1真核表达载体的构建及其抗肺癌作用 Zhongguo Fei Ai Za Zhi 基础研究 BACKGROUND AND OBJECTIVE: WIF-1 is an important tumor-suppressing gene in lung cancer, and its encoding protein WIF-1 can reduce proliferation and promote apoptosis by inhibiting Wnt/β-catenin signaling in lung cancer. This study constructs a eukaryotic expression plasmid carrying WIF-1 using FDA-approved clinical plasmid pVAX and explores the anti-tumor effect of pVAX-WIF-1 on A549 lung cancer cells in vitro and vivo. METHODS: The DNA fragment of human WIF-1 coding sequence was amplified by PCR and was cloned into the multiple cloning sites of eukaryotic expression vector pVAX to construct pVAX-WIF-1. A recombinant plasmid was transfected into lung cancer A549 cells, and the expression of WIF-1 genes was verified by Western blot after transfection. Subsequently, the effect of pVAX-WIF-1 on cell apoptosis and proliferation was identified by MTT assay, staining A549 cells with Hoechst 3235, and flow cytometry. Finally, the A549 subcutaneous xenograft was established to detect the effect of pVAX-WIF-1 on lung tumor growth in vivo. RESULTS: The results of restriction enzyme digestion, PCR, and sequencing indicated that eukaryotic expression plasmid pVAX-WIF-1 was successfully constructed. The protein expression level of WIF-1 was increased in the transfected A549 cells. Further results showed that transfection with pVAX-WIF-1 significantly inhibited proliferation and promoted apoptosis in A549 cells. Moreover, pVAX-WIF-1 significantly inhibited the tumor growth of the A549 subcutaneous xenograft in vivo. CONCLUSION: The recombinant eukaryotic expression vector pVAX-WIF-1 was successfully constructed. Transfection with pVAX-WIF-1 could significantly inhibit proliferation and promote apoptosis of lung cancer A549 cells and also effectively inhibit the tumor growth of the A549 subcutaneous xenograft in vivo. Our research can contribute to clinical applications of WIF-1 in lung cancer gene therapy. 中国肺癌杂志编辑部 2015-07-20 /pmc/articles/PMC6000242/ /pubmed/26182865 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.07.04 Text en 版权所有©《中国肺癌杂志》编辑部2015 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 基础研究
pVAX-WIF-1真核表达载体的构建及其抗肺癌作用
title pVAX-WIF-1真核表达载体的构建及其抗肺癌作用
title_full pVAX-WIF-1真核表达载体的构建及其抗肺癌作用
title_fullStr pVAX-WIF-1真核表达载体的构建及其抗肺癌作用
title_full_unstemmed pVAX-WIF-1真核表达载体的构建及其抗肺癌作用
title_short pVAX-WIF-1真核表达载体的构建及其抗肺癌作用
title_sort pvax-wif-1真核表达载体的构建及其抗肺癌作用
topic 基础研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000242/
https://www.ncbi.nlm.nih.gov/pubmed/26182865
http://dx.doi.org/10.3779/j.issn.1009-3419.2015.07.04
work_keys_str_mv AT pvaxwif1zhēnhébiǎodázàitǐdegòujiànjíqíkàngfèiáizuòyòng
AT pvaxwif1zhēnhébiǎodázàitǐdegòujiànjíqíkàngfèiáizuòyòng
AT pvaxwif1zhēnhébiǎodázàitǐdegòujiànjíqíkàngfèiáizuòyòng
AT pvaxwif1zhēnhébiǎodázàitǐdegòujiànjíqíkàngfèiáizuòyòng
AT pvaxwif1zhēnhébiǎodázàitǐdegòujiànjíqíkàngfèiáizuòyòng
AT pvaxwif1zhēnhébiǎodázàitǐdegòujiànjíqíkàngfèiáizuòyòng
AT pvaxwif1zhēnhébiǎodázàitǐdegòujiànjíqíkàngfèiáizuòyòng